Epigenetic Treatment with Histone Deacetylase Inhibitor Increases Uptake of [111In]In-DOTA-TATE by Neuroendocrine Tumor Cells

I. Klomp; S. U. Dalm; P. M. van Koetsveld; F. Dogan-Oruc; M. de Jong; L. J. Hofland

doi:10.1007/s00259-019-04486-2

Epigenetic Treatment with Histone Deacetylase Inhibitor Increases Uptake of [111In]In-DOTA-TATE by Neuroendocrine Tumor Cells

I. Klomp, S. U. Dalm, P. M. van Koetsveld, F. Dogan-Oruc, M. de Jong, L. J. Hofland

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

Original language	English
Article number	EP-0677
Pages (from-to)	S693-S694
Number of pages	2
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	46
Issue number	SUPPL 1
DOIs	https://doi.org/10.1007/s00259-019-04486-2
Publication status	Published - Oct 2019
Event	32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) - Barcelona, Spain Duration: 12 Oct 2019 → 16 Oct 2019

Access to Document

10.1007/s00259-019-04486-2

Cite this

Klomp, I., Dalm, S. U., van Koetsveld, P. M., Dogan-Oruc, F., de Jong, M., & Hofland, L. J. (2019). Epigenetic Treatment with Histone Deacetylase Inhibitor Increases Uptake of [111In]In-DOTA-TATE by Neuroendocrine Tumor Cells. European Journal of Nuclear Medicine and Molecular Imaging, 46(SUPPL 1), S693-S694. Article EP-0677. https://doi.org/10.1007/s00259-019-04486-2

@article{f549e8fad8b24aada51f3ae5c04cb611,

title = "Epigenetic Treatment with Histone Deacetylase Inhibitor Increases Uptake of [111In]In-DOTA-TATE by Neuroendocrine Tumor Cells",

author = "I. Klomp and Dalm, {S. U.} and {van Koetsveld}, {P. M.} and F. Dogan-Oruc and {de Jong}, M. and Hofland, {L. J.}",

year = "2019",

month = oct,

doi = "10.1007/s00259-019-04486-2",

language = "English",

volume = "46",

pages = "S693--S694",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer-Verlag",

number = "SUPPL 1",

note = "32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) ; Conference date: 12-10-2019 Through 16-10-2019",

}

Klomp, I , Dalm, SU , van Koetsveld, PM , Dogan-Oruc, F, de Jong, M & Hofland, LJ 2019, 'Epigenetic Treatment with Histone Deacetylase Inhibitor Increases Uptake of [111In]In-DOTA-TATE by Neuroendocrine Tumor Cells', European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. SUPPL 1, EP-0677, pp. S693-S694. https://doi.org/10.1007/s00259-019-04486-2

Epigenetic Treatment with Histone Deacetylase Inhibitor Increases Uptake of [111In]In-DOTA-TATE by Neuroendocrine Tumor Cells. / Klomp, I.; Dalm, S. U.; van Koetsveld, P. M. et al.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 46, No. SUPPL 1, EP-0677, 10.2019, p. S693-S694.

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

TY - JOUR

T1 - Epigenetic Treatment with Histone Deacetylase Inhibitor Increases Uptake of [111In]In-DOTA-TATE by Neuroendocrine Tumor Cells

AU - Klomp, I.

AU - Dalm, S. U.

AU - van Koetsveld, P. M.

AU - Dogan-Oruc, F.

AU - de Jong, M.

AU - Hofland, L. J.

PY - 2019/10

Y1 - 2019/10

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000492444406122&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1007/s00259-019-04486-2

DO - 10.1007/s00259-019-04486-2

M3 - Meeting Abstract

SN - 1619-7070

VL - 46

SP - S693-S694

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - SUPPL 1

M1 - EP-0677

T2 - 32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)

Y2 - 12 October 2019 through 16 October 2019

ER -

Epigenetic Treatment with Histone Deacetylase Inhibitor Increases Uptake of [<SUP>111</SUP>In]In-DOTA-TATE by Neuroendocrine Tumor Cells

Access to Document

Other files and links

Cite this